|
Daily Medical Update
Contact dermatitis
Monday, May 18, 2026
|
🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the
last 12 months.
|
Dermatitis : contact, atopic, occupational, drug (2026) - Systematic Review
Key Findings
- Across 374 patients with chronic hand eczema, 80.3% had a partial response or complete resolution within 4-16 weeks of dupilumab treatment.
- Disease severity and quality-of-life scores improved, with stronger responses reported in dyshidrotic, vesicular, atopic, and contact subtypes than in hyperkeratotic disease.
📋 Practice Implication: Reserve dupilumab as a systemic option for refractory chronic hand eczema, especially when conventional topical or occupational measures have not achieved control.
|
Contact dermatitis (2025) - Systematic Review
Key Findings
- Pooled neomycin allergy prevalence was 3.2% in adults and 4.3% in children undergoing patch testing for dermatitis.
- North America had the highest reported prevalence, reaching 6.4% in adults and 8.1% in children, while Europe showed lower rates.
📋 Practice Implication: Keep neomycin on baseline patch-test panels and limit unnecessary topical neomycin exposure, particularly in regions with higher sensitization rates.
|
Contact dermatitis (2026) - Systematic Review
Key Findings
- Among more than 1.5 million dermatitis patients, pooled allergy prevalence was 4.58% for MCI/MI, 5.48% for MI, and 2.09% for BIT.
- Clinical relevance remained high, ranging from 35.3% for BIT to 60.1% for MCI/MI, with the highest prevalence reported in Asia and the Americas.
📋 Practice Implication: Continue routine patch-testing for isothiazolinones and review personal-care, household, and workplace exposures when dermatitis remains unexplained.
|
The British journal of dermatology (2025) - Randomized Controlled Trial
Key Findings
- Compared with a glycerin-based oil-in-water emulsion, physiological lipid supplementation improved stratum corneum ceramide balance and strengthened barrier function.
- In adults with an eczema history, the lipid formulation improved barrier restoration more than a standard moisturizer alone.
📋 Practice Implication: When recurrent eczematous dermatitis reflects barrier fragility, favor moisturizers with physiological lipids rather than basic emollients alone.
|
Contact dermatitis (2025) - Systematic Review
Key Findings
- The pooled analysis found no overall association between atopic dermatitis and contact sensitization, with an odds ratio of 1.08 (95% CI 0.82-1.42).
- Positive associations increased only in selected subgroups, including children or adolescents and sensitization to Compositae mix or sesquiterpene lactone mix.
📋 Practice Implication: Do not assume patients with atopic dermatitis need broader patch-testing solely because of the AD diagnosis; base testing on exposure history and phenotype.
|
|
💡
Summary
Recent contact dermatitis literature reinforces that prevention and targeted allergen identification remain central, while newer therapeutic and barrier-repair strategies may help selected patients with chronic or occupational disease. Systematic reviews show persistent clinically relevant sensitization to neomycin and isothiazolinones, and an updated meta-analysis suggests atopic dermatitis alone should not be treated as a blanket predictor of contact sensitization. Evidence also supports dupilumab for refractory chronic hand eczema and physiological lipid formulations for barrier restoration in patients prone to eczematous flares.
|
|